BKV Insider Sale Notice — 10,000 Common Shares Listed on Form 144

Rhea-AI Filing Summary

BKV Corporation (ticker: BKV) filed a Form 144 reporting a proposed sale of 10,000 common shares through Charles Schwab & Co., Inc. on the NYSE with an aggregate market value of $216,200. The filer shows 84,708,373 shares outstanding, and the shares to be sold were acquired as Founders Shares on 05/01/2020 from BKV Corp. The notice lists two prior sales in the past three months by Lindsay B Larrick: 10,000 shares sold on 06/02/2025 for $216,485 and 10,000 shares sold on 07/01/2025 for $231,307. The filer certifies no undisclosed material adverse information and includes broker details for the planned sale.

Positive

• Required disclosures provided: broker details, acquisition date, class of shares, and aggregate market value are all stated
• Recent sales fully disclosed: two prior sales in the past three months include dates and gross proceeds
• Filer includes standard certification: statement that no undisclosed material adverse information exists

Negative

• Insider selling activity: filer or related person sold 10,000 shares now and disclosed two recent sales totaling 20,000 shares in the past three months
• Potential market perception risk: repeated insider sales could be viewed negatively by some investors, although the filing itself provides no reasons

Insights

Securities Analyst

TL;DR: Routine insider sale notice for 10,000 shares; prior small sales occurred in the past three months.

The Form 144 documents a proposed sale of 10,000 common shares via Charles Schwab on the NYSE with an aggregate market value of $216,200. The filing records acquisition of these shares as founders shares on 05/01/2020 and discloses two recent dispositions totaling 20,000 shares in June and July 2025 with gross proceeds of $216,485 and $231,307 respectively. For investors, these are explicit insider transactions recorded under Rule 144; the absolute sizes are modest relative to the reported 84,708,373 shares outstanding, and the filing contains the standard representation about material nonpublic information.

Corporate Governance Expert

TL;DR: Disclosure follows Rule 144 requirements; raises routine governance transparency questions but shows no regulatory flags.

The notice provides the required broker information, the nature and date of acquisition (founders shares, 05/01/2020), and a representation that no undisclosed material adverse information exists. The record of multiple recent sales by the same person is disclosed openly, which supports transparency. The form does not include any disclaimers or indications of trading-plan reliance beyond the general Rule 10b5-1 language, so governance implications are informational rather than evidencing noncompliance.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	10000	216200.00	84708373	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/01/2020	Founders Shares	BKV Corp			10000	05/01/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Lindsay B Larrick 1200 17TH ST., STE 2100 DENVER CO 80202	BKV Corp	06/02/2025	10000	216485.00
Lindsay B Larrick 1200 17TH ST., STE 2100 DENVER CO 80202	BKV Corp	07/01/2025	10000	231307.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the BKV Form 144 report?

The form reports a proposed sale of 10,000 common shares through Charles Schwab on the NYSE with an aggregate market value of $216,200.

Who is listed as the seller on the recent transactions?

Lindsay B Larrick is listed as the seller for the two recent sales dated 06/02/2025 and 07/01/2025.

When were the shares being sold originally acquired?

The 10,000 shares to be sold were acquired as Founders Shares on 05/01/2020 from BKV Corp.

How many BKV shares are outstanding according to the form?

The filing reports 84,708,373 shares outstanding.

What were the gross proceeds from the recent sales disclosed?

The form shows gross proceeds of $216,485 for 06/02/2025 and $231,307 for 07/01/2025.